No person-to-person spread has been detected, but that doesn’t mean an H5N1 avian influenza pandemic isn’t possible or even probable.

The government wants Moderna to push forward with various bird flu vaccines as well as mRNA shots for other influenza strains with pandemic potential.

The US Department of HHS is awarding the pharmaceutical company Moderna $590 million to continue developing a vaccine to protect against bird flu.

Avian influenza A (H5N1) has caused at least 67 ... What People Are Saying Then HHS Secretary Xavier Becerra in a statement: "Avian flu variants have proven to be particularly unpredictable ...

In 2023, Moderna initiated a study on a “pandemic influenza vaccine” to protect against H5 and H7 avian influenza viruses ... Biden-Harris Administration and HHS,” HHS Secretary Xavier Becerra said in a statement Friday. “Accelerating the ...

The Department of Health and Human Services (HHS) will award roughly $590 million to Moderna to accelerate the development of mRNA-based pandemic influenza vaccines, including vaccines for avian flu strains, to ensure the United States is better prepared for future potential pandemics, according to a recent HHS news release.

Moderna has been awarded approximately $590 million from the federal government to help speed up the development of an mRNA-based bird flu vaccine, health officials said.

Companies including Moderna and Pfizer are working on mRNA vaccines for bird flu. Read more at straitstimes.com.

The government is working to head off human bird flu infections. The U.S. government has awarded Moderna $590 million to advance the development of its bird flu vaccine, as the country doubles down on efforts to tackle increasing infections in humans.

The funding, which follows the $176 million the government awarded Moderna in June 2024, aims to get mRNA vaccines ready before bird flu strains currently circulating in the wild and on farms can potentially cause human outbreaks.

The US Department of Health and Human Services has decided to spend nearly $600 million on the development of a bird flu vaccine.According to CNN, HSS on Friday, January 17, 2025, announced that it will award $590 million to Moderna to resume

The U.S. government has awarded Moderna $590 million to advance the development of its bird flu vaccine, as the country doubles down on efforts to tackle increasing infections in humans.